Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate ...

Julia Louis-Dreyfus is opening up about the heartbreaking impact Alzheimer’s disease has had on her family. During a Thursday ...

The 'Veep' alum sat for an hour-long career retrospective conversation on Thursday in Cannes with ‘Awards Chatter' host Scott ...

INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...

As Natalie Morales gets older, conversations about brain health “hit hard.” In an exclusive interview with PEOPLE, the CBS ...

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

Biogen unveiled mixed results Thursday for its tau-targeting Alzheimer's treatment, leading the stock to drop.

Biogen Inc. said it will advance its experimental Alzheimer’s drug after getting promising though inconclusive signs of ...

While Biogen’s tau-targeting therapy didn’t demonstrate improvement on a dementia severity scale, the company touted ...

Scientists tracking more than 40,000 people for over 15 years found an intriguing connection between egg consumption and ...

For years, the great hope in Alzheimer’s research has been that if scientists could clear the brain of Alzheimer’s physical ...